Dan Peng

1.8k total citations
80 papers, 1.4k citations indexed

About

Dan Peng is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Dan Peng has authored 80 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 15 papers in Surgery and 14 papers in Oncology. Recurrent topics in Dan Peng's work include Bone Metabolism and Diseases (11 papers), Bone health and treatments (6 papers) and Parathyroid Disorders and Treatments (6 papers). Dan Peng is often cited by papers focused on Bone Metabolism and Diseases (11 papers), Bone health and treatments (6 papers) and Parathyroid Disorders and Treatments (6 papers). Dan Peng collaborates with scholars based in China, United States and Australia. Dan Peng's co-authors include Zhengxiao Ouyang, Xia Chen, Yi Shen, Wei Zhu, Ziqing Yin, Lu Wan, Tang Liu, Dongchi Zhao, Gang Yu and Бо Лю and has published in prestigious journals such as PLoS ONE, Journal of Bone and Joint Surgery and Biochemical and Biophysical Research Communications.

In The Last Decade

Dan Peng

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Peng China 22 626 242 236 193 145 80 1.4k
Yaping Pan China 33 925 1.5× 197 0.8× 281 1.2× 176 0.9× 102 0.7× 127 3.0k
Jiawei Chen China 23 534 0.9× 112 0.5× 232 1.0× 133 0.7× 125 0.9× 128 1.5k
Zhengting Wang China 24 826 1.3× 314 1.3× 166 0.7× 235 1.2× 126 0.9× 87 1.9k
Daisuke Hirayama Japan 18 505 0.8× 135 0.6× 273 1.2× 237 1.2× 80 0.6× 51 1.6k
Wenhua Zhao China 26 815 1.3× 338 1.4× 287 1.2× 427 2.2× 65 0.4× 119 2.2k
Hongyan Diao China 27 888 1.4× 239 1.0× 439 1.9× 250 1.3× 254 1.8× 105 2.1k
Dan Huang China 24 458 0.7× 112 0.5× 258 1.1× 198 1.0× 282 1.9× 79 1.6k
Hong Hua China 26 508 0.8× 133 0.5× 189 0.8× 177 0.9× 210 1.4× 116 2.1k
Zhou Zhou China 24 473 0.8× 109 0.5× 272 1.2× 123 0.6× 101 0.7× 80 1.7k
Hai Zou China 21 546 0.9× 146 0.6× 299 1.3× 189 1.0× 54 0.4× 76 1.6k

Countries citing papers authored by Dan Peng

Since Specialization
Citations

This map shows the geographic impact of Dan Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Peng more than expected).

Fields of papers citing papers by Dan Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Peng. The network helps show where Dan Peng may publish in the future.

Co-authorship network of co-authors of Dan Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Peng. A scholar is included among the top collaborators of Dan Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Peng. Dan Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Dan, et al.. (2025). Ultrasound-responsive nanocarriers for cancer therapy: Physiochemical features-directed design. Journal of Controlled Release. 388(Pt 1). 114353–114353.
2.
3.
Peng, Dan, Yu Peng, Guang Zhao, et al.. (2024). The new pattern for dual NOTCH pathway involving nuclear transcription and mitochondrial regulation supports therapeutic mechanism of 4-butyl benzophenone derivatives against SIRS. Free Radical Biology and Medicine. 223. 306–324. 5 indexed citations
5.
Peng, Dan, Jinfang Sun, Jinyi Wang, Qi Xiao, & Guoxing Li. (2021). Burden of Skin Disease — China, 1990−2019. China CDC Weekly. 3(22). 472–475. 9 indexed citations
6.
Pan, Yueying, Shuchang Zhou, Yujin Wang, et al.. (2021). IgG4-Related Disease: A Retrospective Chinese Study of Features and Treatment Response of 98 Patients Including 4 Rare Cases. Current Medical Science. 41(2). 390–397. 4 indexed citations
7.
Zhang, Yuanyuan, et al.. (2019). A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy. Journal for ImmunoTherapy of Cancer. 7(1). 51–51. 15 indexed citations
8.
Yin, Ziqing, Wei Zhu, Qi Wu, et al.. (2019). Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways. European Journal of Pharmacology. 859. 172550–172550. 61 indexed citations
9.
Zhu, Wei, Ziqing Yin, Qiang Zhang, et al.. (2018). Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment. Biochemical and Biophysical Research Communications. 509(1). 294–300. 38 indexed citations
10.
Ouyang, Zhengxiao, Min Xu, Xianan Li, & Dan Peng. (2014). Dysplasia Epiphysealis Hemimelica with Involvement of the Distal Tibial Epiphysis and Talus: Recurrence of a Case and Literature Review. The Journal of Foot & Ankle Surgery. 53(2). 199–202. 7 indexed citations
12.
Jin, Yi, Dan Peng, Yi Shen, et al.. (2013). MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha. DNA and Cell Biology. 32(6). 302–309. 43 indexed citations
13.
Peng, Dan, Houjuan Zuo, Zhengxiang Liu, et al.. (2012). The tetraspanin CD151-ARSA mutant inhibits angiogenesis via the YRSL sequence. Molecular Medicine Reports. 7(3). 836–842. 6 indexed citations
14.
Liu, Bo, Yi Wu, & Dan Peng. (2012). Astrocyte elevated gene-1 regulates osteosarcoma cell invasion and chemoresistance via endothelin-1/endothelin A receptor signaling. Oncology Letters. 5(2). 505–510. 15 indexed citations
15.
Liu, Tang, Xiangsheng Zhang, Zhihong Li, & Dan Peng. (2011). Management of Combined Bone Defect and Limb-length Discrepancy After Tibial Chronic Osteomyelitis. Orthopedics. 34(8). e363–7. 18 indexed citations
16.
Liu, Weifeng, Houjuan Zuo, Dan Peng, et al.. (2011). Role of tetraspanin CD151–α3/α6 integrin complex: Implication in angiogenesis. The International Journal of Biochemistry & Cell Biology. 43(4). 642–650. 21 indexed citations
17.
Xie, Zhongjian, Ying Chen, Sally D. Pennypacker, Zhiguang Zhou, & Dan Peng. (2010). The SH3 domain, but not the catalytic domain, is required for phospholipase C-γ1 to mediate epidermal growth factor-induced mitogenesis. Biochemical and Biophysical Research Communications. 398(4). 719–722. 12 indexed citations
18.
Guo, Hui, Dan Peng, Min Xu, et al.. (2010). Report of two FOP cases with 617G>A mutation in the ACVR1 gene from Chinese population. Clinical Dysmorphology. 19(4). 206–208. 3 indexed citations
19.
Bu, Yanhong, Yuling He, Hou‐De Zhou, et al.. (2010). Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells. Journal of Endocrinology. 206(3). 271–277. 23 indexed citations
20.
Zhang, Yingying, et al.. (2009). Investigation of natural Borna disease virus infection in peripheral blood mononuclear cells of some cattle and pigs in Chongqing.. Chinese Veterinary Science. 39(12). 1045–1050. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026